Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell Activation After Antibody-Dependent Cellular Phagocytosis (ADCP-mediated T-cell activation)
- Target
- ADCP-mediated T-cell activation
- Molecular classification
- Immune process, Cellular signaling pathway
01
Overview
T-cell activation after antibody-dependent cellular phagocytosis (ADCP) refers to the process by which T cells are primed and activated as a downstream consequence of phagocytes engulfing antibody-opsonized target cells. This mechanism is crucial in linking innate immune clearance with adaptive immune responses, particularly in contexts such as cancer immunotherapy and antiviral defense. ADCP leads to antigen presentation by phagocytes, resulting in T cell activation, enhanced cytotoxicity, and immunological memory.
- Other names
- ADCP-induced T cell responseT cell priming via ADCPAdaptive immunity following ADCP
02
Mechanism of action
ADCP by phagocytes leads to antigen presentation and T cell activation.
03
Biological functions
T cell activationAntigen presentationAdaptive immune responseCytotoxicityImmunological memory
04
Disease associations
Cancer immunotherapyInfectious disease immunity
05
Safety considerations
Cytokine release syndrome (CRS)Off-target effects of antibodiesImmune-related adverse events (irAEs)
06
Interacting drugs
Monoclonal antibodies (e.g., anti-CD20, anti-HER2)
2 more in the full profile.
07
Biomarkers
T cell infiltration in tumor microenvironmentExpression of activation markers on T cells (e.g., CD69, CD25)Cytokine production by T cells (e.g., IFN-gamma, TNF-alpha)Fc receptor polymorphisms
Beyond the preview
Go deeper on T-cell Activation After Antibody-Dependent Cellular Phagocytosis (ADCP-mediated T-cell activation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T-cell Activation After Antibody-Dependent Cellular Phagocytosis (ADCP-mediated T-cell activation).